|
| 药明康德(603259)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2024-03-22 | 10.14 | 0.00% | 295347.98 | 0.00 | 256630.23 | 86.89% | 股权激励限售股份 | | 2024-03-07 | 8.36 | 0.00% | 295337.84 | 10.14 | 256621.87 | 86.89% | 股权激励限售股份 | | 2023-07-03 | 540.21 | 0.18% | 296741.95 | 20.94 | 255947.38 | 86.25% | 股权激励限售股份 | | 2023-05-08 | 13.13 | 0.00% | 296181.28 | 561.14 | 255913.78 | 86.24% | 股权激励限售股份 | | 2023-03-24 | 10.14 | 0.00% | 295634.56 | 574.27 | 255891.63 | 86.39% | 股权激励限售股份 | | 2023-03-07 | 4.18 | 0.00% | 295424.09 | 584.41 | 255887.46 | 86.45% | 股权激励限售股份 | | 2022-07-01 | 591.67 | 0.20% | 295024.61 | 654.82 | 255807.48 | 86.52% | 股权激励限售股份 | | 2022-05-12 | 378.61 | 0.13% | 294344.91 | 1246.49 | 255127.78 | 86.31% | 股权激励限售股份 | | 2022-05-09 | 16.66 | 0.01% | 293966.30 | 1625.10 | 254749.17 | 86.18% | 股权激励限售股份 | | 2022-03-23 | 17.59 | 0.01% | 293933.45 | 1641.76 | 254716.33 | 86.18% | 股权激励限售股份 | | 2022-03-01 | 4.18 | 0.00% | 293915.87 | 1659.35 | 254698.74 | 86.17% | 股权激励限售股份 | | 2021-12-31 | 595.91 | 0.20% | 254664.09 | 1685.27 | 256349.36 | 86.74% | 股权激励限售流通 | | 2021-11-12 | 379.20 | 0.13% | 254664.09 | 1685.27 | 256349.36 | 86.74% | 股权激励限售流通 | | 2021-11-08 | 16.66 | 0.01% | 254664.09 | 1685.27 | 256349.36 | 86.74% | 股权激励限售流通 | | 2021-07-01 | 826.00 | 0.28% | 254600.10 | 1754.37 | 256354.47 | 86.93% | 股权激励限售流通 | | 2021-05-12 | 334.62 | 0.14% | 211335.53 | 2150.31 | 213485.84 | 87.11% | 股权激励限售流通 | | 2021-05-10 | 63378.46 | 25.86% | 211000.92 | 2484.93 | 213485.84 | 87.11% | 发行前股份限售流通 | | 2021-05-07 | 19.91 | 0.01% | 147622.46 | 65863.39 | 213485.84 | 87.11% | 股权激励限售流通 | | 2021-03-24 | 6269.03 | 2.56% | 147602.55 | 65883.30 | 213485.84 | 87.12% | 增发A股原股东配售上市 | | 2021-03-05 | 3.48 | 0.00% | 141333.52 | 72152.32 | 213485.84 | 87.13% | 股权激励限售流通 | | 2020-05-12 | 330.90 | 0.20% | 100938.55 | 47122.75 | 148061.30 | 89.67% | 股权激励限售流通 | | 2019-05-08 | 61442.75 | 52.51% | 71862.61 | 32964.08 | 104826.69 | 89.59% | 发行前股份限售流通 |
|